TrialThe journal of headache and pain2025

Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial.

Lauren Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.